Senior-Led Teams
Every functional area is led by someone with more than 20 years of hands-on experience in early-phase development.
Inventio Science
Senior-Led FSP for Early-Phase Clinical Development
Phase I–II programmes executed with precision, accountability, and regulatory rigour, across Europe, North America, APAC, and LATAM.
The problem we solve
Why Early-Phase Outsourcing Fails, and How We Fix It
Most FSP and CRO partnerships fail at the same predictable points: accountability blurs across functional handoffs, sponsor SOPs get interpreted rather than followed, and junior staff are left managing decisions that need senior judgement. Programmes slip. Data gaps appear. Inspections reveal what governance should have caught.
Inventio Science is built around a different model, we keep experienced experts at the point of execution, not just the point of oversight.
01
No layers
Every functional area is led by someone with 20+ years of hands-on experience in early-phase development.
02
Sponsor SOP execution
Not interpretation: we work to your quality standards, governance frameworks, and ways of working.
03
Transparent governance
Milestone status in real time, so course-correction happens before problems escalate.
04
Inspection-readiness
Documentation standards, audit trails, and data-quality controls are embedded from Day 1, not retrofitted before an inspection.
05
Senior continuity
Our cohesive, long-standing team means none of the disruption of CRO staff turnover.
Inventio Science’s FSP model combines senior scientific expertise with disciplined operational execution, so your Phase I–II programmes reach milestones reliably, your data is defensible, and your regulatory relationships stay intact.
What we deliver
Functional Service Provider Solutions for Biotechnology and Academic Drug Development
We run First-in-Human (FIH), dose-escalation, healthy-volunteer, and Phase I–II patient studies for biotech companies, academic sponsors, and CROs. Fixed-scope engagements or fully integrated FSP coverage, both models bring the same senior team to your programme.
“Senior people in the pitch. The same senior people in the trial.”Duchesse Kala-Kala, Founder & CEO, Inventio Science
From molecule to Phase II
See how we support emerging biotech from nonclinical package to Phase II
One relationship. No gaps between preclinical and clinical. Smooth oversight from strategy to execution.
What makes it work
- Senior-led teams with direct sponsor access
- Sponsor SOP execution, not interpretation
- Transparent programme governance
- Inspection-readiness built in
- Senior continuity, no handovers
Sponsor SOP Execution
We work to your quality standards, governance frameworks and ways of working, not our own defaults.
Transparent Governance
Milestone status in real time, so course-correction happens before problems escalate.
Inspection-Readiness
Documentation standards, audit trails and data-quality controls are embedded from Day 1.
Senior Continuity
Our cohesive, long-standing team means none of the disruption of CRO staff turnover.
Let’s talk about your programme
Whether you have a specific functional gap, a full Phase I programme to resource, or a question about our approach, the right starting point is a conversation.